He is experienced in military medicine, an FAA medical examiner, human performance expert, and fighter pilot
But the expert consensus is now that semaglutide and other GLP-1 drugs do not increase the risk of pancreatitis, says Drucker
Studies and real-world use suggest that the injectable formulation can offer a more predictable and manageable side effect profile for most patients
This dual action may provide enhanced appetite suppression and metabolic benefits for some patients, potentially leading to greater weight loss
This, according to Parnacott, is largely due to its dual-action mechanism. Developing a medication that targets two distinct pathways in the body required a more complex production process, extensive clinical trials, and significant research investments, he explains